Now Reading: Hyderabad pharmacies face hurdles in cancer drug price cut rollout
-
01
Hyderabad pharmacies face hurdles in cancer drug price cut rollout
The Story in Brief
Hyderabad chemists say cheaper cancer medicines may take days or weeks to reach retail shelves following revised MRPs. Pharmacies and stockists are concerned about losses on existing inventories bought at higher prices and are seeking adjustments from manufacturers.
Senior office-bearers of the Telangana Druggists and Chemists Association said retail shops were caught in a bind. They had paid upfront or secured credit for multi-crore inventories of oncology drugs procured at pre-revision prices. Selling existing stocks at the new lower prices would cause catastrophic losses, they said, and the drugs must be sent back upstream for MRP reprinting.
Industry leaders argued that regulators should have ensured sufficient stock with revised prices was available before enforcing an overnight cutoff. Chemists warned of temporary supply bottlenecks until manufacturers issue credit adjustments and fresh stock bearing the revised MRPs reaches the market.
Indian Opinion Analysis
The implementation gap means patients may not see lower prices at the counter for weeks. The chemists’ demand for credit adjustments shifts the financial burden onto manufacturers, who now must decide whether to absorb losses on legacy inventory or risk supply disruptions. The association has named no next step, leaving the standoff between retailers and drugmakers unresolved. The practical timeline for the price cuts to reach patients depends entirely on how quickly manufacturers process reprints and adjustments.
Source: telanganatoday.com
This brief was synthesised by AI from the source linked above. Methodology and corrections.
